Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial disorders.

Massimo Zeviani1, Stefano Di Donato

  • 1Division of Molecular Neurogenetics, Istituto Nazionale Neurologico C. Besta, Via Celoria 11 20133 Milan, Italy. zeviani@istituto-besta.it

Brain : a Journal of Neurology
|September 11, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study From the EUSTAR Cohort.

Arthritis care & research·2026
Same author

Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains.

Clinical rheumatology·2026
Same author

Defining Enthesitis on Ultrasound in Spondyloarthritis: Lessons From the DEUS Initiative and the Path Forward.

The Journal of rheumatology·2026
Same author

Exploiting a unified vascular framework to predict organ-specific complications and accomplish disease modification in systemic sclerosis.

The Lancet. Rheumatology·2025
Same author

Cross-validation and sensitivity to change of EULAR ScleroID as a measure of function and impact of disease in patients with systemic sclerosis.

RMD open·2025
Same author

Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre study.

Seminars in arthritis and rheumatism·2025
Same journal

Disrupted WWOX-MYC interplay impairs neurogenesis in human brain organoids.

Brain : a journal of neurology·2026
Same journal

SMPD4 deficiency disrupts indirect neurogenesis and neuronal migration in gyrencephalic cortex.

Brain : a journal of neurology·2026
Same journal

Retinal hyper-reflective foci link retinal and cortical pathology in paediatric multiple sclerosis.

Brain : a journal of neurology·2026
Same journal

Two scripts, two pathways: dorsal-ventral biases in post-stroke kana-kanji agraphia.

Brain : a journal of neurology·2026
Same journal

Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity.

Brain : a journal of neurology·2026
Same journal

Time to reconsider risk for psychosis?

Brain : a journal of neurology·2026
See all related articles

Mitochondrial disorders involve impaired oxidative phosphorylation (OXPHOS) due to defects in either nuclear or mitochondrial DNA. This review covers genetic diseases affecting OXPHOS.

Area of Science:

  • Biochemistry
  • Genetics
  • Cell Biology

Background:

  • Mitochondrial disorders are linked to impaired oxidative phosphorylation (OXPHOS), the final stage of cellular energy metabolism.
  • OXPHOS involves a multi-subunit respiratory chain embedded in the inner mitochondrial membrane.
  • Defects can arise from issues within the respiratory chain complexes themselves.

Purpose of the Study:

  • To review human genetic diseases caused by mutations affecting oxidative phosphorylation (OXPHOS).
  • To explore the genetic basis of mitochondrial disorders stemming from nuclear and mitochondrial DNA defects.
  • To provide an overview of conditions resulting in impaired OXPHOS.

Main Methods:

  • Literature review of genetic diseases impacting mitochondrial energy metabolism.

Related Experiment Videos

  • Analysis of the genetic architecture of the respiratory chain, involving both nuclear and mitochondrial genomes.
  • Categorization of mitochondrial disorders based on inheritance patterns (mendelian and cytoplasmic).

    • Main Results:

    • Oxidative phosphorylation (OXPHOS) defects can result from mutations in either the nuclear or mitochondrial genome.
    • The respiratory chain relies on a complex interplay between proteins encoded by both genomes.
    • Mitochondrial disorders encompass a range of conditions with diverse genetic origins affecting OXPHOS.

    Conclusions:

    • Genetic defects in either nuclear DNA or mitochondrial DNA can lead to impaired OXPHOS and mitochondrial disorders.
    • Understanding the dual genetic control of the respiratory chain is crucial for diagnosing and treating these conditions.
    • This review highlights the spectrum of human genetic diseases associated with OXPHOS dysfunction.